MedPath

Quantification of myocardial fibrosis with cardiovascular magnetic resonance imaging in patients with muscular dystrophy

Not Applicable
Conditions
Muscular dystrophy
Registration Number
JPRN-UMIN000037608
Lead Sponsor
Hokkaido University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
11
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with impaired renal function (estimated glomerular filtration rate <30 mL/min/1.73m2) 2. Patients with claustrophobia 3. Patients expected to live a year or less 4. Patients who contact persons judge as ineligible for this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The prespecified primary outcome of the study is to assess improvement of left ventricular ejection fraction 24 months after the first cardiovascular magnetic resonance imaging in patients with muscular dystrophy, suspected muscular dystrophy carriers, and volunteers.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath